Overview

Remgro Limited and ⁤investment⁣ Holding Limited (IHL) announced⁢ on Monday, December 1, 2025, an in-principle, non-binding agreement to restructure their joint interests in Mediclinic Holdings.The proposed transaction would see Remgro acquiring full ownership of Mediclinic Southern Africa, while IHL would gain ‍full ownership of Hirslanden, Mediclinic’s Swiss operations.

Details of the Proposed Transaction

Under the proposed agreement, Remgro will take⁤ full control⁤ of mediclinic Southern Africa, encompassing operations within ⁤South Africa.IHL,a unit of MSC Mediterranean shipping Company Holding,will acquire complete ownership of Hirslanden,Mediclinic’s network of hospitals ‍and clinics in Switzerland.

⁢ ⁣ Both Remgro and IHL will maintain their existing joint interests ‍in the Middle East operations and Spire Healthcare Group Plc, a UK-based healthcare provider. This indicates a strategic focus on maintaining a ‍collaborative presence in specific geographic markets.

Timeline and Approvals

The parties are aiming to finalize a transaction implementation agreement ⁢in early 2026, with an anticipated⁢ implementation date by the end of the fourth quarter of 2026.

⁢ ⁤ The transaction remains subject to several key conditions, including:
‍

• Finalization of negotiations
• Execution of definitive and binding transaction agreements
• Receipt of all necessary regulatory approvals in relevant jurisdictions
• Approval from the boards of directors of both Remgro ⁢and IHL

Market Reaction

⁣ Remgro’s shares⁣ experienced a positive market reaction following the proclamation, rising 2.27% to ⁤R177.80 in⁢ early trade ‍on December 1, 2025. This increase brings Remgro’s year-to-date gains to 17%.

Cautionary⁣ Note

⁣ Remgro ⁣has advised its shareholders to exercise caution when ⁣dealing in their securities, given that negotiations ‍are ongoing and ⁣subject to finalization. Further⁤ announcements will be‍ made⁣ as the process progresses.
‍